InSite Vision Commences Phase 1/2 Clinical Study Of ISV-303 For Post-Surgical Ocular Pain And Swelling
Links shared publicly online about this topic.
- 922total visits
InSite Vision Commences Phase 1/2 Clinical Study Of ISV-303 For Post-Surgical Ocular Pain And Swelling
InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, announced the initiation of a Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory product
View full resource at medicalnewstoday.com
Tags: Edema, Pain, Vision, Clinical Trial
Most Recently Shared on August 25, 2010 at 1:00 pm By:
InSite Vision Commences Phase 1/2 Clinical Study Of ISV-303 For Post-Surgical Ocular Pain And Swelling http://mnt.to/3HNr #clinicaltrials
Also Shared By:
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling
medicalnewstoday.com — “InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, has announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial” View full resource at medicalnewstoday.com
Most Recently Shared on January 10, 2011 at 1:05 pm By:
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling http://mnt.to/3PMj
Advertisement
MNT Eye Health
@mnt_eyehealth
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling http://mnt.to/3PMj
1 year ago...